JUVENESCENCE: INVESTING IN THE
AGE OF LONGEVITY

With their previous books published over the past 9 years, Mellon and Chalabi have established an excellent track record of recognising investment opportunities before they become mainstream, starting with forecasting the Great Recession in 2008, and identifying gold as an excellent hedge. More recently, they have written about life sciences, and their recommended stocks in Cracking the Code have outperformed every major market in the world. Equally their main stock picks in Fast Forward have yielded market busting returns.

A discussion on the personal benefits of a healthy life explaining what is good and what is bad for you and how current research indicates that making small changes can reap significant rewards which lead to longer, healthier lives.

By reducing the impact of diseases such as diabetes, osteoporosis through medical research and increasing healthy lifestyles, the risk of suffering in old age is significantly reduced

Millions of people die from medical conditions caused by aging each year. Recent discoveries and anticipated near term developments in the understanding of the ageing process at the cellular and molecular level are going to be some of the most important contributors to repairing damaged cells and slowing or potentially reversing the root causes of ageing. Breakthroughs in gene editing techniques, stem cell therapies, immunotherapies and artificial intelligence all hold great promise.

PAPERBACK & ELECTRONIC VERSIONS

SOLD OUT
AWAITING REPRINT £16.99

*Includes £2 towards P&P for UK mainland delivery addresses only.

Contact [email protected] for overseas delivery.

ALSO AVAILABLE FROM HARRIMAN HOUSE OR AMAZON
Juvenescence is a clarion call for all the retooling of industry to meet the demands of the largest demographic trends of our time; namely the age wave
Mike West
Co-Chief Executive, Biotime
Live longer, healthier and compress morbid state of sickness at end of life into a few weeks
David Sinclair
Harvard Medical School
A fountain of opportunity for investors ready to capitalize on the promise of longevity for people everywhere
Paul Irving
Chairman, Milken Institute Center for the Future of Aging